Stories: The Prostate Myths Still Confusing Us

Listen to this article. Choose between:

For many men, the prostate is not something they think about very much for most of their lives. It is a small gland that quietly does its job and rarely attracts attention. Then, sometime in the second half of life, the subject begins to appear more often. A doctor might mention it during a routine visit. A friend may talk about getting a PSA test. Someone in your social circle might be diagnosed with prostate cancer. Around the same time, subtle changes can begin to appear in everyday life. You might notice that your urinary stream feels a little different than it once did, or that you occasionally wake up during the night to use the bathroom. None of these changes necessarily feel dramatic, but they are enough to introduce a new question that was rarely present earlier in life: What exactly is going on with my prostate?

Once that question appears, many men quickly discover that the answers can feel surprisingly unclear. Some health organizations encourage discussions about PSA screening, while others emphasize the risks of overdiagnosis and unnecessary treatment. Friends may share stories that range from reassuring to frightening. One man might describe a cancer that was discovered early and managed easily, while another might talk about surgery or radiation therapy. The result is a confusing mixture of messages. Prostate problems are said to be common but also serious. Screening can be helpful but also controversial. Symptoms may matter, yet doctors sometimes say the disease can develop without them. It is not surprising that many men come away from these conversations unsure about what signals actually matter. Part of the difficulty is that the prostate does not operate in isolation. It sits inside a system involving hormones, bladder function, aging tissue, and metabolic changes that unfold gradually over decades.

Part of the confusion comes from how common prostate conditions actually are. Benign prostatic hyperplasia, the gradual enlargement of the gland that occurs in many men as they age, affects a large proportion of men over fifty and becomes even more widespread in later decades. At the same time, prostate cancer is also common. The Canadian Cancer Society estimates that about one in nine men in Canada will be diagnosed with prostate cancer during their lifetime. Yet only about one in thirty-four men will die from the disease. Those numbers reveal something important: prostate cancer is common and often far less deadly than many people assume.

When a condition combines high prevalence with a wide range of possible outcomes, people naturally begin looking for simple ways to make sense of it. Over time those shortcuts become informal rules that circulate through conversations and media coverage. If there are no symptoms, everything must be fine. If cancer is discovered, it must be aggressive. PSA tests must either solve the problem or be useless. Urinary changes must simply be part of getting older. Treatments must inevitably lead to difficult side effects. Each of these beliefs contains a small piece of truth, which is why they feel convincing. But each also oversimplifies how prostate biology, screening, and treatment decisions actually work.

The goal of this article is not to turn readers into their own physicians or to settle the ongoing debates surrounding prostate screening. Instead, it is to replace a handful of persistent myths with a clearer way of thinking about prostate health in the second half of life. When you look more closely at how the prostate changes with age, how prostate cancer develops, and how modern screening and treatment strategies work, a more nuanced picture begins to emerge.

The first myth appears almost automatically when the subject of prostate health arises, because it reflects the way many of us have learned to interpret our bodies: if nothing feels wrong, then nothing serious can be happening. It is a comforting assumption. Unfortunately, when it comes to the prostate, it is not always correct.

For many men, prostate health first enters awareness in a very ordinary way. Maybe you begin waking once during the night to use the bathroom. Maybe your urinary stream feels a little weaker than it did ten years ago. Or perhaps nothing has changed at all, and the subject only comes up because a friend mentions a PSA test or a doctor raises the topic during a routine visit. In moments like these, most people fall back on a simple rule they have used their entire lives: if something serious were wrong, the body would let you know. Pain or disruption would appear and demand attention. If nothing feels unusual, everything must be fine. It is a reassuring way to think about health, and in many situations it works reasonably well. The prostate, however, is one place where that rule can quietly break down.

Part of the reason is that the prostate changes naturally with age in ways that do not always produce obvious signals. Benign prostatic hyperplasia, the gradual enlargement of the gland that many men develop, becomes increasingly common with age. Yet the experience of that enlargement varies widely. Some men with large prostates notice very little change in urination, while others with only modest enlargement experience frequent nighttime trips to the bathroom or a hesitant urinary stream. Educational materials from the National Institute of Diabetes and Digestive and Kidney Diseases highlight this mismatch between prostate size and symptoms.

Prostate cancer adds another layer to the story because it often develops quietly in its earliest stages. Many people assume prostate cancer would quickly interfere with urination, but the anatomy of the gland makes that less likely. A large proportion of prostate cancers begin in the outer regions of the prostate rather than the part surrounding the urethra. Because of this location, a tumor can grow for some time without affecting the flow of urine. Patient information from organizations such as the NHS and the Mayo Clinic notes that early prostate cancer frequently produces no symptoms at all.

This silent phase helps explain why prostate cancer is sometimes detected through screening rather than through symptoms. Feeling well is obviously a good sign, but it is not a definitive signal about what is happening inside the prostate.

Understanding this can actually reduce unnecessary worry. Symptoms are useful clues, but they are only one part of the picture. In midlife and beyond, the body often changes quietly before it changes loudly. Recognizing that pattern allows men to think about prostate health with a little more perspective and a little less reliance on the old assumption that silence always means everything is fine.

But once that first myth begins to loosen its grip, another assumption often takes its place. If prostate cancer can exist silently, many men instinctively swing to the opposite conclusion: that prostate cancer must always be aggressive, dangerous, and life-threatening. The reality, as we will see next, is far more nuanced.

When most people hear the word cancer, their mind goes immediately to the worst-case scenario. Cancer is something most people imagine spreading quickly and demanding urgent treatment. It is one of the most feared diagnoses in modern medicine, and that fear shapes how many of us think about prostate cancer long before we ever learn much about it. If cancer is discovered, the instinctive assumption is that something dangerous has been found and that it must be dealt with immediately.

But prostate cancer behaves very differently from the picture most people carry in their minds.

One of the first things that surprises many men when they begin learning about prostate cancer is how common it actually is. The Canadian Cancer Society estimates that roughly one in nine men in Canada will be diagnosed with prostate cancer during their lifetime. Yet only about one in thirty-four men will die from the disease. Those numbers reveal something important: prostate cancer is common, but many men diagnosed with it will never die from it.

Research over the past two decades has helped explain why. Prostate cancer does not behave like a single disease. Some prostate cancers grow quickly and spread beyond the prostate if they are not treated. Others grow so slowly that they may never cause symptoms or shorten a man’s life. Population data summarized by Statistics Canada show that when prostate cancer is detected early, survival rates approach 100 percent.

Because of this wide range of behavior, doctors have gradually changed how they approach certain prostate cancer diagnoses. In the past, treatment was often immediate once cancer was discovered. Today, physicians sometimes recommend careful observation instead. This approach, known as active surveillance, involves monitoring the cancer over time with repeat PSA testing, imaging, and periodic reassessment. Treatment begins only if the cancer shows signs of becoming more aggressive. Clinical guidelines now recognize active surveillance as an appropriate strategy for many men with low-risk prostate cancer.

Understanding this spectrum changes how the diagnosis itself is interpreted. The word cancer still matters, and in some cases it demands urgent treatment. But it does not automatically mean the same outcome in every situation. Some prostate cancers require decisive action, while others can be monitored safely for years.

And once that spectrum becomes clear, another question naturally follows. If prostate cancer can range from very slow-growing to potentially dangerous, how do doctors decide when something deserves closer investigation? That question leads directly to one of the most debated tools in men’s health: the PSA test.

Conversations about prostate health often shift quickly to one particular blood test: PSA. Ask a group of men in their fifties or sixties what they have heard about it and you will often hear two very different reactions. Some believe the test is an essential early warning system that can detect prostate cancer before symptoms appear. Others have heard that PSA testing leads to false alarms, unnecessary biopsies, and treatments that may never have been needed. When these two stories circulate at the same time, it is easy to fall into a simple conclusion: the PSA test must either be extremely helpful or essentially useless.

In reality, the test sits somewhere in between.

PSA stands for prostate-specific antigen, a protein produced by cells that can be detected in the bloodstream. Higher levels sometimes appear when prostate cancer is present, which is why the test became widely used as a screening tool beginning in the late twentieth century. But PSA levels can rise for many different reasons. Benign prostatic hyperplasia, inflammation, infections, or even recent ejaculation or cycling can temporarily increase PSA values. Information from the Canadian Cancer Society notes that fluctuations like these are common, which means that a single elevated result does not automatically indicate cancer.

At the same time, PSA testing has shown measurable benefits when examined across large populations. Reviews of screening studies summarized by organizations such as the United States Preventive Services Task Force suggest that PSA-based screening can modestly reduce deaths from prostate cancer in certain age groups, particularly among men between fifty-five and sixty-nine. Yet these same analyses also highlight the trade-offs involved. Many men with elevated PSA levels undergo further testing, including prostate biopsies, only to discover that no cancer is present. Others are diagnosed with cancers that may never have caused symptoms during their lifetime.

This is why physicians increasingly treat PSA results as signals rather than verdicts. A PSA value is one piece of information about how the prostate is behaving. Doctors often repeat the test to confirm that an elevated level persists, and additional tools such as multiparametric MRI may be used before deciding whether a biopsy is necessary. Guidelines from organizations like the Canadian Urological Association increasingly recommend this kind of stepwise evaluation rather than acting on a single result.

Seen this way, the PSA test becomes less mysterious. It is not useless, but it is also not definitive. It is one tool among several that physicians use to understand what may be happening inside the prostate.

And once that becomes clear, another assumption often begins to surface. Because prostate enlargement becomes so common with age, many men quietly conclude that prostate problems are simply inevitable. The next myth grows directly from that belief.

Talk with a group of men in their fifties or sixties about urinary changes and a familiar tone often appears. Someone mentions waking more often during the night to use the bathroom. Another jokes about planning road trips around rest stops. The conversation often ends with a shrug and a familiar phrase: Well, that’s just part of getting older. Over time this idea becomes so widely accepted that many men stop thinking of prostate symptoms as something worth paying attention to. If prostate problems happen to everyone eventually, then there is not much reason to question them.

There is a small piece of truth inside that belief, which is part of what makes the myth so persistent. The prostate does change with age. Benign prostatic hyperplasia, the gradual enlargement of the gland that many men develop later in life, becomes increasingly common after the age of fifty. When a biological change becomes this widespread, it is easy to see how it begins to feel inevitable.

But common does not mean universal, and it certainly does not mean that every man will experience the same symptoms. One of the more surprising findings in urological research is how loosely prostate size and urinary symptoms are connected. Educational resources from the National Institute of Diabetes and Digestive and Kidney Diseases note that some men with large prostates experience very few urinary problems, while others with only modest enlargement notice significant changes in urination. Symptom severity depends on interactions between the prostate, bladder muscle, and the nerves that coordinate urination.

Because of this variability, physicians increasingly think about urinary symptoms as the result of interacting systems rather than a single unavoidable process. Lifestyle adjustments, medications that relax prostate or bladder muscles, and other non-surgical treatments can often reduce symptoms when they become bothersome.

Seen this way, prostate changes in midlife look less like an unavoidable fate and more like a biological trend with many possible outcomes. Aging increases the probability of certain prostate conditions, but it does not lock every man into the same experience.

And once that distinction becomes clear, another familiar assumption begins to look different as well. Many men who wake during the night to urinate assume they are simply experiencing a normal consequence of aging or prostate enlargement. In reality, nighttime urination can have several different causes, many of which extend beyond the prostate itself. That brings us to the next myth.

Nighttime often becomes the moment when men first notice that something about their urinary patterns has changed. A trip or two to the bathroom that were not there a few years earlier. Over time it can begin to feel routine, something that simply arrives with age. Friends mention the same experience, and conversations quietly confirm that others are dealing with it too. Eventually the explanation settles into place: this must just be part of getting older.

There is a reason this belief becomes so widespread. Nighttime urination, known medically as nocturia, does become more common as people age. Research shows many adults over sixty wake at least once during the night to urinate. When something becomes this common, it naturally begins to feel normal.

Part of the confusion comes from the way nocturia is often linked to the prostate in everyday conversation. Because prostate enlargement can influence urine flow, many men assume the prostate must be responsible whenever they wake during the night to use the bathroom. Sometimes that assumption is correct. Benign prostatic hyperplasia can contribute to increased urinary frequency. But research over the past two decades has shown that nocturia often reflects several interacting systems rather than the prostate alone.

In some cases the explanation lies in the kidneys, which may produce more urine overnight as fluid regulation shifts with age. In others, sleep itself plays a role. Studies examining sleep disorders have found that conditions such as obstructive sleep apnea can increase nighttime urine production and lead to repeated awakenings. Medications, metabolic conditions like diabetes, and evening fluid intake can also influence how often someone wakes during the night. Physiologically, nocturia is often a signal emerging from several systems working together.

This is why physicians often ask a wide range of questions when someone reports frequent nighttime urination. They may ask about sleep quality, medications, fluid intake patterns, or other health conditions that might influence urine production. The goal is not simply to attribute the symptom to aging or prostate enlargement, but to understand which system is actually producing the signal.

Seen through this wider lens, the assumption that nighttime urination is simply “part of getting older” begins to soften. It may be common in midlife and beyond, but it does not always arise from the same cause and it is not always driven by the prostate alone.

And once conversations about prostate health move beyond symptoms and screening, another concern often appears quickly. Many men quietly worry about what treatment might mean if prostate cancer is ever diagnosed. Stories about surgery, radiation, and long-term side effects circulate widely, sometimes leaving the impression that treatment inevitably leads to serious problems with sexual function or urinary control. The final myth grows out of that fear.

Conversations about prostate cancer treatment often shift quickly toward a particular fear. Even men who know relatively little about the disease itself have often heard stories about surgery or radiation leading to long-term problems with sexual function or urinary control. Over time they create a powerful impression: if prostate cancer is treated, the cost will almost certainly be impotence, incontinence, or both.

There is a reason these concerns persist. Prostate cancer treatments occur in a region where nerves controlling erections and bladder function run close to the prostate. When surgery or radiation is directed at this area, surrounding tissues can be affected. Research published in journals such as JAMA has shown that urinary incontinence and erectile dysfunction are more common after certain prostate cancer treatments, particularly in the period following surgery.

But the key word in the myth is inevitably, and that part of the story is far less accurate.

Over the past two decades, both surgical techniques and treatment strategies have evolved substantially. One important development is nerve-sparing prostatectomy, a surgical approach designed to preserve the nerve bundles that regulate erections whenever it is safe to do so. Clinical studies show that preserving these nerves can improve the likelihood of recovering sexual function after surgery, particularly in men who had good function before treatment. Recovery varies between people, but the presence of long-term side effects is no longer considered unavoidable.

At the same time, physicians have become more selective about when treatment is necessary at all. As we saw earlier, many prostate cancers grow slowly and may never threaten a man’s life. For certain low-risk cancers, doctors increasingly recommend active surveillance rather than immediate treatment. This approach involves monitoring the cancer with periodic PSA testing, imaging, and follow-up assessments. By delaying or avoiding treatment in appropriate cases, active surveillance allows many men to avoid treatment-related side effects while still maintaining excellent long-term cancer outcomes.

Even when treatment is required, outcomes vary widely depending on factors such as age, overall health, cancer stage, and the treatment method chosen. Surgery, radiation therapy, and newer targeted approaches each carry different profiles of potential side effects. Over time many men also experience partial or substantial recovery of urinary control or sexual function as the body heals and adapts.

Understanding these nuances replaces a frightening oversimplification with a more accurate perspective. Side effects from prostate cancer treatment are real and deserve careful discussion, but they are not inevitable and they do not occur in the same way for every patient. Treatment decisions today increasingly aim to balance cancer control with preserving quality of life.

And once these myths are viewed together, a deeper pattern begins to appear. Each one grows from the same instinct to simplify a complex biological system into clear yes-or-no rules. In reality, prostate health rarely behaves that way. Understanding why these myths form helps bring the larger picture into focus — and that broader pattern is where we turn next.

After hearing these six myths laid out one by one, a pattern begins to emerge. Each myth takes a complicated biological reality and compresses it into a simple rule. If there are no symptoms, nothing is wrong. If cancer is discovered, it must be deadly. If a test exists, it must either solve the problem or be worthless. If symptoms appear with age, they must be inevitable. If treatment is required, the consequences must be severe. These rules feel comforting because they simplify uncertainty. But the prostate does not operate according to simple rules.

Research across urology, epidemiology, and clinical medicine consistently shows that prostate health unfolds along a spectrum. The prostate itself changes gradually with age, with benign enlargement becoming common in later decades. Prostate cancer, as national statistics and clinical studies show, ranges from slow growing tumors that may never threaten a man’s life to more aggressive forms that require timely treatment. Screening tools such as PSA testing provide useful signals but must be interpreted within a broader diagnostic process. Symptoms like nocturia can arise from several interacting systems rather than from the prostate alone. And treatment outcomes vary depending on factors such as age, baseline health, cancer characteristics, and the specific approach chosen.

In other words, the prostate is part of a system, not a single switch that flips from healthy to diseased.

This is one of the reasons prostate health can feel confusing in the second half of life. Human beings naturally prefer clear signals and definitive answers. But biology often communicates in probabilities rather than certainties. A symptom may suggest several possibilities. A test may indicate a risk rather than a diagnosis. A condition may progress slowly for years or remain stable indefinitely. Physicians spend much of their time interpreting these signals, weighing evidence, and helping patients understand what the information likely means rather than what it guarantees.

When prostate health is viewed through this systems lens, the apparent contradictions surrounding screening, symptoms, and treatment begin to make more sense. Different recommendations and experiences are not necessarily signs that medicine is confused. More often they reflect the reality that prostate health involves several interacting processes that unfold over time.

For men navigating the second half of life, this perspective can be surprisingly stabilizing. It replaces the search for simple yes or no answers with a more realistic understanding of how the body actually works. And once that shift in perspective happens, it becomes easier to think about prostate health in a calmer and more constructive way. The next step is learning how to interpret these signals in everyday life.

Once the myths surrounding prostate health begin to fall away, most men are left with a practical question: what should I actually do with this information? The goal is not to turn every man into his own physician or to create anxiety about a gland that will change naturally with age. Instead, the goal is to develop a clearer way of interpreting the signals the body produces and to know when those signals deserve a closer look.

One of the most useful shifts is learning to think in terms of patterns rather than isolated symptoms. A single night of waking to urinate, for example, rarely means very much. But a gradual change that persists for weeks or months may be worth discussing with a physician. Clinical resources describing lower urinary tract symptoms note that patterns such as increasing urinary frequency, difficulty starting urination, or a persistently weak stream can reflect benign prostate enlargement or other conditions affecting the bladder and urinary tract. Paying attention to patterns over time helps physicians distinguish between normal day-to-day variation and changes that deserve further evaluation.

A second helpful step is treating screening as a conversation rather than a decision made in isolation. Because PSA testing carries both benefits and trade-offs, most clinical guidelines recommend shared decision-making between a patient and physician. The United States Preventive Services Task Force, for example, suggests that men between the ages of fifty-five and sixty-nine discuss the potential advantages and risks of PSA screening with their doctor before deciding whether testing makes sense for them. Similar recommendations appear in Canadian urological guidance, which emphasizes confirming elevated PSA results and considering additional tools such as imaging before moving toward biopsy. In practical terms, this means that a PSA test works best when it is part of an ongoing dialogue about health history, family risk, and personal preferences.

Another practical habit is treating nighttime urination and urinary changes as signals worth decoding rather than dismissing automatically. Occasional nighttime awakenings are common, but persistent nocturia can sometimes reflect sleep disorders, medication effects, fluid intake patterns, or metabolic conditions in addition to prostate enlargement. Research examining sleep and nocturia has shown links between nighttime urination and conditions such as obstructive sleep apnea. When physicians explore these broader possibilities, they often uncover solutions that improve sleep and overall health, not just urinary symptoms.

Men can also benefit from remembering that many prostate conditions develop slowly, which allows time for thoughtful decisions. For example, active surveillance has become a common strategy for managing certain low-risk prostate cancers, allowing physicians to monitor the disease carefully before deciding whether treatment is necessary. Clinical guidelines from major urological organizations describe this approach as a safe option for many men with low-risk tumors, helping them avoid unnecessary treatment while maintaining excellent long-term outcomes. Knowing that immediate action is not always required can make conversations about diagnosis and treatment feel far less overwhelming.

Finally, it helps to approach prostate health the same way physicians do: as one component of overall health rather than an isolated problem. Regular medical checkups, attention to sleep quality, physical activity, and managing chronic conditions such as diabetes or high blood pressure all influence how the body functions over time. These broader health patterns affect the same systems that influence urinary function, hormone regulation, and recovery after medical treatment.

Taken together, these habits of thinking do not eliminate uncertainty, but they do make it easier to navigate. Instead of relying on myths or worrying about worst-case scenarios, men can approach prostate health with a clearer framework: watch for patterns, have informed conversations about screening, investigate persistent symptoms, and recognize that many prostate conditions unfold slowly enough to allow thoughtful decisions. With that perspective in place, the changes that occur in the prostate during the second half of life begin to look less mysterious and far more manageable.

By the time men reach the second half of life, the body begins sending signals a little more often than it once did. Sleep may feel more fragile. Small physiological shifts that once went unnoticed begin to appear in daily routines. The prostate is one place where these changes become visible. It often enlarges gradually with age, responds to shifting hormones, and occasionally develops cancers that range from harmless to serious. None of this means that something has gone wrong. It means the body is moving through a phase of life where biological systems become more expressive.

From this perspective, prostate health becomes less about detecting hidden threats and more about interpreting signals accurately. Research in urology and population health shows that the prostate rarely behaves in simple yes-or-no patterns. Symptoms do not always correspond neatly with anatomy, and screening tests provide useful information without offering definitive answers on their own.

Many myths surrounding prostate health arise when people try to force this complexity into simple rules. If symptoms are absent, everything must be fine. If cancer appears, it must be dangerous. If treatment is required, the consequences must be severe. In reality, prostate health unfolds along a spectrum shaped by aging, genetics, lifestyle, and the natural variability of human biology.

In the end, the prostate is not a mysterious organ that suddenly turns against the body. It is part of a larger system that continues adapting as the decades pass. When its signals are understood in that broader context, the fear and confusion that often surround prostate health begin to fade, replaced by something far more useful: perspective.

It emerges from how multiple systems interact and adapt over time, often in ways that aren’t obvious when viewed in isolation.

If you want a clearer way to think about that, I’ve outlined the systems perspective in a short guide you can download here:

The Midlife Health Reset — 10 core systems that shape strength, energy, and long-term health after 50.

Sources

Canadian Cancer Society. (2024). Prostate cancer statistics. https://cancer.ca/en/cancer-information/cancer-types/prostate/statistics

Canadian Task Force on Preventive Health Care. (2014). Recommendations on screening for prostate cancer with the prostate-specific antigen test. https://canadiantaskforce.ca/prostate-cancer-clinician-summary/

Carter, H. B., et al. (2013). Early detection of prostate cancer: AUA guideline. The Journal of Urology, 190(2), 419–426. https://pubmed.ncbi.nlm.nih.gov/23659877/

National Institute of Diabetes and Digestive and Kidney Diseases. (2022). Enlarged prostate (benign prostatic hyperplasia). https://www.niddk.nih.gov/health-information/urologic-diseases/prostate-problems/enlarged-prostate-benign-prostatic-hyperplasia

National Health Service. (n.d.). Symptoms of prostate cancer. NHS. https://www.nhs.uk/conditions/prostate-cancer/symptoms/

Resnick, M. J., et al. (2013). Long-term functional outcomes after treatment for localized prostate cancer. New England Journal of Medicine, 368(5), 436–445. https://pmc.ncbi.nlm.nih.gov/articles/PMC3742365/

Grossman, D. C., et al. (2018). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. JAMA, 319(18), 1901–1913. https://doi.org/10.1001/jama.2018.3710

van Kerrebroeck, P., et al. (2002). The standardisation of terminology in nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics, 21(2), 179–183. https://doi.org/10.1002/nau.10053